临床精神医学杂志
臨床精神醫學雜誌
림상정신의학잡지
JOURNAL OF CLINICAL PSYCHOLOGICAL MEDICINE
2015年
4期
271-272
,共2页
姚明荣%费玉娥%濮正平%陈菲%王莲娥%查显友
姚明榮%費玉娥%濮正平%陳菲%王蓮娥%查顯友
요명영%비옥아%복정평%진비%왕련아%사현우
盐酸美金刚%血管性痴呆%脑源性神经营养因子
鹽痠美金剛%血管性癡呆%腦源性神經營養因子
염산미금강%혈관성치태%뇌원성신경영양인자
memantine hydrochloride%vascular dementia%brain derived neurotrophic factor
目的:探讨盐酸美金刚对血管性痴呆(VaD)患者的临床疗效和对血清脑源性神经营养因子(BDNF)水平的影响。方法:采用随机双盲法将70例 VaD 患者分为治疗组和对照组,分别给予盐酸美金刚和安慰剂治疗6个月;分别于治疗前和治疗3、6个月给予简易精神状态检查(MMSE)、日常生活能力量表(ADL)评分和血清 BDNF 水平检测。结果:治疗后治疗组 MMSE 评分及血清 BDNF 水平明显提高,ADL 评分明显下降(P ﹤0.05或 P ﹤0.01);对照组以上各指标治疗前后差异无统计学意义。结论:盐酸美金刚对 VaD 患者认知、行为能力有改善作用,可能与提高血清 BDNF 水平有关。
目的:探討鹽痠美金剛對血管性癡呆(VaD)患者的臨床療效和對血清腦源性神經營養因子(BDNF)水平的影響。方法:採用隨機雙盲法將70例 VaD 患者分為治療組和對照組,分彆給予鹽痠美金剛和安慰劑治療6箇月;分彆于治療前和治療3、6箇月給予簡易精神狀態檢查(MMSE)、日常生活能力量錶(ADL)評分和血清 BDNF 水平檢測。結果:治療後治療組 MMSE 評分及血清 BDNF 水平明顯提高,ADL 評分明顯下降(P ﹤0.05或 P ﹤0.01);對照組以上各指標治療前後差異無統計學意義。結論:鹽痠美金剛對 VaD 患者認知、行為能力有改善作用,可能與提高血清 BDNF 水平有關。
목적:탐토염산미금강대혈관성치태(VaD)환자적림상료효화대혈청뇌원성신경영양인자(BDNF)수평적영향。방법:채용수궤쌍맹법장70례 VaD 환자분위치료조화대조조,분별급여염산미금강화안위제치료6개월;분별우치료전화치료3、6개월급여간역정신상태검사(MMSE)、일상생활능역량표(ADL)평분화혈청 BDNF 수평검측。결과:치료후치료조 MMSE 평분급혈청 BDNF 수평명현제고,ADL 평분명현하강(P ﹤0.05혹 P ﹤0.01);대조조이상각지표치료전후차이무통계학의의。결론:염산미금강대 VaD 환자인지、행위능력유개선작용,가능여제고혈청 BDNF 수평유관。
Objective:To explore the clincal curative effect of hydrochloride and the change of serum level of brain derived neurotrophic factor(BDNF)in patients with vascular dementia(VaD). Method:U-sing the randomized double blind method,the 70 VaD patients were divided into treatment group and control group;and treated by memantine hydrochloride and the placebo respectively for 6 months. All of the patients were assessed by mini mental dementia examination(MMSE)and activities of daily living(ADL);and their se-rum brain derived neurotrophic factor(BDNF)level was detected before treatment and 3,6 months after treat-ment. Results:Compared with before treatment,the score of MMSE and the level of serum BDNF in the treat-ment group were significantly higher,and the scores of ADL was significantly lower(P ﹤ 0. 05 or P ﹤ 0. 01);but there were no significant change in the control group. Conclusion:Memantine hydrochloride can improve the cognitive and behavioral ability in VaD patients. Its may be related to increased the level of serum BDNF.